Advagene Biopharma Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced operating loss was TWD 32.646 million compared to TWD 35.774 million a year ago. Net loss was TWD 31.759 million compared to TWD 34.602 million a year ago. Basic loss per share was TWD 0.72 compared to TWD 0.78 a year ago.